Edwards Lifesciences Corp 4

SVP and Corporate Controller Andrew M. Dahl had 253 Edwards Lifesciences Corp (EW) shares withheld to cover taxes on vested equity awards, leaving him with about 14,615 shares owned.

On September 13, 2026, Edwards Lifesciences Corp SVP and Corporate Controller Andrew M. Dahl had 253 shares of common stock withheld by the company to cover tax obligations arising from the vesting of equity awards, in a transaction coded “F” under Rule 16b-3(e). These shares were effectively surrendered to the issuer at an implied price of about $84.37 per share, for an estimated value of roughly $21,350, and are considered a routine, non-discretionary equity compensation-related transaction rather than an open-market trade. Following this withholding, Dahl directly owns approximately 14,615 shares of Edwards Lifesciences common stock, with an estimated market value of about $1.25 million based on the current share price.

Filing Facts

CIK

1099800

Ticker

EW

Form

4

Source Type

sec

Accession

0001225208-26-007811

Alert Tier

4